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Introduction
Breast cancer (BC) is a common malignancy around the world, and more than 370,000 women die due to BC worldwide each year (Wang et al., 2017) . The main cause of BC morbidity and mortality is an incurable metastatic disease that is highly resistant to traditional therapies (Xu et al., 2017) .
Despite the advances in diagnosis and therapy, such as surgery, chemotherapy and radiation, there are high rates of recurrence and metastasis among patients with BC (Wang et al., 2015) . Besides, continuous treatment with radiotherapy and chemotherapy leads to less effective destruction of cancer cells due to the acquired resistance (Vimalraj et al., 2013) . Therefore, the molecular mechanisms underlying BC tumorigenesis need to be further investigated.
Long noncoding RNAs (lncRNAs) are defined as transcripts that have more than 200 nucleotides and lack protein-coding capacity (Xu et al., 2017) . LncRNAs have been reported to involve in tumor progression and metastasis through regulating different levels biological processes, such as mRNA alternative splicing, protein activities, changes of protein localization, etc (Huarte, 2015; Xu et al., 2017) . A growing number of literatures reported that lncRNAs are tightly linked to human cancer and involved in the control of availability for specific miRNAs (Bartonicek et al., 2016) . In BC, a number of differentially expressed lncRNAs and their correlation with tumorigenic functions were reported (Xi et al., 2017; Yan et al., 2017; Zhou et al., 2017) . For example, lncFOXO1 was notably down-regulated in BC and inhibited the growth of BC by increasing FOXO1 transcription (Xi et al., 2017) . While, linc-ITGB1 was greatly up-regulated in BC which promoted cell metastasis (Yan et al., 2017) . DSCAM (Down Syndrome Cell Adhesion Molecule) antisense lncRNA (DSCAM-AS1), located on 21q22.2, is transcribed from the antisense strand of DSCAM belonging to the immunoglobulin superfamily of cell adhesion molecules (Zhao et al., 2014) . Several literatures have reported that 5 DSCAM-AS1 is associated with the progression of cancer cells (Miano et al., 2016; Niknafs et al., 2016; Zhao et al., 2014) . Zhao et al. found that DSCAM-AS1 was overexpressed in lung adenocarcinoma and might interact with their host genes to accomplish the function of different subtypes of lung cancer (Zhao et al., 2014) . Miano et al. discovered that overexpression of DSCAM-AS1 promoted the growth of a luminal breast cancer cell line (Miano et al., 2016) . Of note, Yashar S et al. showed that DSCAM-AS1 could interact with hnRNPL to mediate tumor progression (Niknafs et al., 2016) . However, the whole story of how DSCAM-AS1-mediated luminal breast cancer growth and progression largely remains unkown. Therefore, a further understanding of DSCAM-AS1-regulated targets and networks is needed.
MicroRNAs (miRNAs) are small noncoding RNA molecules of 19-25 nucleotides and can act as post-transcriptional regulators by binding to complementary sequences of target mRNAs (Zeng et al., 2016) . MiRNAs were involved in cellular processes including cell proliferation, differentiation and apoptosis (Li et al., 2014; Liu and Li, 2015; Wang et al., 2017; Zeng et al., 2016) . A host of evidences have revealed that dysregulation of miRNAs is associated with BC tumorigenesis and metastasis. MiR-204-5p is a type of microRNA, and previously studies have reported that miR-204-5p was down-regulated in several human cancers and might act as a tumor inhibitor (Luo et al., 2017) . For example, low levels of miR-204-5p expression were confirmed in hepatocellular carcinoma (Luo et al., 2017) , oral squamous cell carcinoma (Wang et al., 2016) , gastric cancer (Zhang et al., 2015) , papillary thyroid carcinoma (Liu et al., 2015) and glioma (Xia et al., 2015) . (Imam et al., 2012) . Yet no study focused on the correlation between miR-204-5p and DSCAM-AS1.
Ribonucleotide reductase M2 (RRM2) is the catalytic subunit of ribonucleotide reductase which is an essential enzyme involved in DNA synthesis, and can regulate its enzymatic activity (Iwamoto et al., 2015) . Several publications have reported that RRM2 was overexpressed in diverse cancer cells (Zhong et al., 2016) . Dysregulation of RRM2 in BC has been previously investigated in some literatures. For instance, RRM2 was up-regulated in BC cells and could act as a critical marker for aggressive BC (Lu et al., 2012) . Shah et al. found that inhibition of RRM2 suppressed in vivo tumor growth and decreased cell migratory and invasive in BC (Putluri et al., 2014) . Several studies indicated the role of RRM2 as a target of miRNA in human cancers. The results of our experiments clarified the regulation mechanism between RRM2 and miR-204-5p.
In current study, we measured the expression level of DSCAM-AS1 and miR-204-5p in BC cells.
Subsequently, we employed dual-luciferase reporter system to verify the correlation of DSCAM-AS1 and miR-204-5p. Afterwards, the effects of DSCAM-AS1 on BC proliferation, growth metastasis and apoptosis were measured by a series of in vitro experiments including cell apoptosis assay, CCK-8 assay and transwell assay and in vivo experiments. In addition, we also explored the impacts of RRM2 on BC cell activities and tumor growth. These results highlighted that DSCAM-AS1 may be a promising therapeutic strategy for treatment of human BC.
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Materials and methods
Tissue specimens
BC tissues and adjacent tissues were collected between January 2014 and August 2015 from 40 patients of the Affiliated Center Hospital, Xinxiang Medical University. All specimens were gathered from women aged 44-71 (average age: 62.3). Patients did not receive any chemotherapy or radiation therapy before surgery. All tissue samples were independently checked by three pathologists or doctors before preserving in liquid nitrogen at -80°C or transferring to microcentrifuge tubes containing TRIzol reagent for RNA extraction. The relevant characteristics of these 40 patients are described in Table 1 . All experiments were performed with the informed consent of the patients and under the approval of the Affiliated Center Hospital, Xinxiang Medical University.
Cell culture
Human breast cancer cell line HCC1937 and human embryonic kidney cell line HEK293 were purchased from Chinese Academy of Sciences cell bank (Shanghai, China). HCC1937 cells were cultured in the RPMI-1640 medium (GIBCO, Grand Island, NY, USA) plus 10% (v/v) fetal bovine serum (FBS), 1.5g/L of NaHCO 3 , 2.5g/L glucose, 0.11 g/L sodium pyruvate and 1%(v/v) penicillin-streptomycin. HEK293 cells were maintained in DMEM medium supplemented with 10%(v/v) FBS AND 1%(v/v) penicillin-streptomycin.
Microarray analysis
The breast tumor tissue data was collected from TCGA database. The 'DESeq2' R-package was utilized to normalize, identify and visualize differentially expressed miRNAs and lncRNAs 
Cell transfection
Overexpression of DSCAM-AS1 (isoform 2), the predominant isoform, was obtained by PCR and cloned into pLenti6.1 vector (Invitrogen, CA, USA), and shDSCAM-AS1(shRNA) was purchased from GenePharma (Shanghai, China). For in vitro assays, transient transfection in HCC1937 cells was performed using Lipofectamine 3000 (Invitrogen, CA, USA) for pLenti6.1-DSCAM-AS1 and pLenti6.1-shDSCAM-AS1, MiR-204-5p mimics (GenePharma, Shanghai, China), and miR-NC(non-targeting control) (GenePharma, Shanghai, China). Cells were divided into different groups by two ways. The first group settings were as follows: cells transfected with pLenti6.1 and miR-NC served as NC group; cells transfected with pLenti6.1 and miR-204-5p was regarded as miR-204-5p group; cells transfected with pLenti6.1-DSCAM-AS1and miR-NC served as DSCAM-AS1 group; cells transfected with pLenti6.1-DSCAM-AS1 and miR-204-5p was regarded as DSCAM-AS1+miR-204-5p group. The second group settings were as follows: cells transfected with pLenti6.1 and miR-NC served as NC group; cells transfected with pLenti6.1 and miR-204-5p was regarded as miR-204-5p group; cells transfected with pcDNA3.1-RRM2 and miR-NC served as RRM2 group; cells transfected with pcDNA3.1-RRM2 and miR-204-5p was regarded as RRM2+miR-204-5p group. Transfection was performed by Lipofectamine 3000 (Invitrogen, CA, USA) following the manufacturer's protocols. All fragments and inserts were confirmed by sequencing.
QRT-PCR
TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) and NanoDrop 2000 (Thermo Fisher Scientific Inc., USA) were used to extract and quantify total RNA, respectively. Reverse transcription was performed with 200 ng total RNA by using PrimeScript High Fidelity RT-PCR Kit (Takara, Japan).
QRT-PCR was performed using PowerUp™ SYBR™ Green Master Mix (Thermo-Fisher) with a
QuantStudio™ 3 Real-Time PCR System(Thermo-Fisher) according to the manufacturer's instructions. U6 and GADPH were used as internal references. 2 −∆∆Ct method was employed to 9 quantify relative mRNA expression values. The specific primers used are presented in Table 2 .
Western blot
Protein samples were lysed in RIPA buffer (Beyotime, Shanghai, China) with a cocktail of protease inhibitor (Roche, Basel, Switzerland). After centrifugation, supernatant protein concentration was measured by Bradford Reagent (Bio-Rad, CA, USA). After eluted with SDS-loading buffer, proteins were electrophoresed in 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) gel, transferred to nitrocellulose membranes (Millipore, USA) and blocked. Primary antibodies (anti-RRM2, ab172476, 1:2000; anti-GAPDH, ab181603, 1:10000, Abcam, Cambridge, MA, USA) were added. After extensively washed with TBST, secondary anti-body was added (Goat anti-Rabbit IgG H&L (HRP), ab6721, 1:2000, Abcam, Cambridge, MA, USA) for 1.5 h. Signal detection was carried out by immunoblotting with an ECL system (Life Technology, USA). For relative quantification, we normalized GADPH expression level (as gray level) to 1, and compared the expression levels (gray level) of different experimental groups via ImageJ software.
Flow cytometry
Cell apoptosis was assessed by Annexin V-PE Apoptosis Detection Kit (Beyotime, Shanghai, China) following the manufacturer's protocols. 48 hours after transfection, cells were washed re-suspended in binding buffer containing propidium iodide (PI) and annexin V-FITC. Stained cells were analyzed by BD Accuri C6 flow cytometer (BD, USA) using Cell Quest Pro software (BD, USA). Multi-Mode Detection Platform (Molecular Devices, USA).
CCK-8 assay
Transwell assay
Cells were suspended in serum-free medium and placed into the upper chamber with coated Matrigel of a 24-well chamber (Sigma-Aldrich, MO, USA). Six-hundred-microliter media 1 0 containing 10% FBS were added to the lower chamber overnight. Migrated cells were fixed with 4% paraformaldehyde and stained with crystal violet. Cells were rinsed and counted from random fields (×100 magnification). Each experiment was conducted triplicate.
Luciferase reporter assays
Twenty-four hours before transfection HEK293 cells were seeded onto a 24-well plate (1×10 5 /well), then the cells were co-transfected with pCMV-Renilla (Promega, WI, USA) and firefly luciferase reporter plasmids pGL3 (Promega, WI, USA) containing negative control ( luminometer.
Animal experiment
For in vivo trials, HEK293T were transduced in the presence of 8ug/ml polybrene and grown in culture medium containing 2ug/ml puromycin to generate pLenti6.1-DSCAM-AS1 and pLenti6.1-shDSCAM-AS1 lentiviral particles. HCC1937 cells were transduced by these lentiviral particles. Then, cells were cultured in the medium with 3ug/ml blasticidin for stable cell line selection before subcutaneously injected into the right flank of female nude mice(6-8 weeks old).
The tumor sizes were measured every 5 d using caliper. The volume of tumor was estimated using the fomula V=(π/6)(W 2 *L), where W=width and L=length of the tumor. 30 days post-injection, mice were sacrificed and the size of tumor was used as the endpoint of reading. All animal studies 1 1
were approved by the Affiliated Center Hospital, Xinxiang Medical University and in accordance with the norms of The Affiliated Center Hospital, Xinxiang Medical University. The data are presented as the mean volume X±S.E.
Statistical analysis
All experiments were repeated at least three times. All statistical analyses were performed using GraphPad Prism 6.0 software (GraphPad Software Inc., USA). The measured parameters are presented as the mean ± SD. One-way analysis of variance (ANOVA) followed by Tukey's test were used to compare the differences among groups. Statistical significance is presented in figures by *, P<0.05, **, P<0.01.
Results
Identification of DSCAM-AS1 is an up-regulated lncRNA in breast tumor
We initially focused on investigating the most differentially expressed lncRNAs and miRNAs in breast cancer tissue compared to benign adjacent tissue from 1097 tissue samples. All differentially expressed lncRNAs and miRNAs with a filtration standard of log 2 |Fold Change|>1 and P.adjust<0.05 were demonstrated in a volcano map ( Figure 1A was highly expressed in luminal breast cancer tissues in comparison to adjacent normal tissues. We also found others researches have indicated that miR-204-5p is a breast tumor suppressor gene, 1 2 which is also in line with our analysis. Thus, we were eager to further validate our bioinformatics analysis, we employed qRT-PCR to detect DSCAM-AS1 levels in BC tissue and normal adjacent tissue samples of forty hospital patients. The results indicated that in comparison with normal adjacent tissues, DSCAM-AS1 was up-regulated ( Figure 1E, P<0.05) while miR-204-5p was down-regulated ( Figure 1F, P<0.05) in BC tissue samples.
DSCAM-AS1 target on miR-204-5p
Then, we were wondering the target candidates of DSCAM-AS1 and miR-204-5p. Interestingly, via
Targetscan and Miranda database, we predicted two potential target sites (Region 406-427 and
Region 685-706) between DSCAM-AS1 and 3'UTR of miR-204-5p. Thus, we constructed the luciferase reporter and performed the trials as mentioned in the Material&Methods section, the results verified our prediction and confirmed that DSCAM-AS1 could regulate the 3'UTR of miR-204-5p (Figure 2A-B) . The results of qRT-PCR showed that cells were successfully transfected with DSCAM-AS1, and the content of miR-204-5p was impaired when overexpressing DSCAM-AS1 ( Figure 2C-D) . In conclusion, DSCAM-AS1 could regulate on 3'UTR of miR-204-5p.
DSCAM-AS1 promoted BC cells proliferation and metastasis and impeded cell apoptosis by targeting miR-204-5p
The experiments were performed in four groups: NC group, miR-204-5p group, DSCAM-AS1 group and miR-204-5p+DSCAM-AS1 group. CCK-8 results showed that DSCAM-AS1 promoted the proliferation of BC cells, which was inhibited by miR-204-5p ( Figure 3A, P<0.01 Therefore, miR-204-5p served as tumor inhibitor by impeding the acceleration of DSCAM-AS1 on BC cells progression. Taken together, these panels demonstrated that DSCAM-AS1 has an inhibitory effect on miR-204-5p to promote BC cells proliferation and metastasis.
MiR-204-5p could act on RRM2
We hypothesized that RRM2 was a downstream of miR-204-5p and the target sites between them were predicted by using Targetscan and Miranda database. We mutated Region 1949-1956 of RRM2 as mentioned in the left panel Figure 4A . As verified by dual luciferase reporter assay, we confirmed that RRM2 is a target of miR-204-5p (right panel, Figure 4A , P<0.01). Meanwhile, we used QRT-PCR and western blot to separately detect the mRNA and protein expression of RRM2 in BC tissue and adjacent tissue samples. As shown in Figure 4B and 4C, we verified higher expression of RRM2 in BC tissues ( Figure 4B-C, both P<0.05) . In order to investigate the regulation of miR-204-5p on RRM2, we transfected HCC1937 cells with three different constructs or constructs combinations, the qRT-PCR results revealed that the expression of RRM2 were significantly inhibited by miR-204-5p ( Figure 4D-E, P<0.01 ).
RRM2 promoted BC cells reproduction and metastasis and impeded cell apoptosis which was reversely changed by miR-204-5p
Experimental groups were performed as follows: NC group, miR-204-5p group, RRM2 group and miR-204-5p+RRM2 group. The CCK-8 results revealed that the miR-204-5p effectively reduced BC cells viability while RRM2 increased it, and in miR-204-5p+RRM2 group, miR-204-5p largely suppressed the BC cells survival rate which was largely increased by RRM2. (Figure 5A, P<0.01) .
We used transwell assays to detect RRM2's function on BC cell migration and invasion. As shown in Figure 5B -5D, miR-204-5p effectively inhibited the migration and invasion of BC cells, whereas RRM2 significantly enhanced these abilities of BC cells, and in co-transfection group of RRM2 and miR-204-5p, miR-204-5p had largely inhibited the migration and invasion of BC cells which was increased by RRM2. Next, we applied cell apoptosis assay and Flow cytometry technique to confirm RRM2's function on BC cell apoptosis. The results indicated that RRM2 impeded cancer 1 4 cell apoptosis, while the inhibitory effect of RRM2 was reversely changed by the participation of miR-204-5p ( Figure 5E, P<0.01) . Together, these results revealed that miR-204-5p may have an inhibitory effect on RRM2 to suppress BC cells growth and progression.
Overexpression of DSCAM-AS1 promoted tumor growth
In order to investigate DSCAM-AS1's tumor promotion effect in vivo, we separately injected equal numbers (10 6 or 2 × 10 6 ) of negative control (NC), DSCAM-AS1 or sh-DSCAM-AS1 transduced HCC1937 cells into nude mice, the relative expression levels of each group were validated by qRT-PCR. The results of qRT-PCR indicated that DSCAM-AS1 expression was significantly increased in DSCAM-AS1 transfected HCC1937 cell group, while it was decreased in sh-DSCAM-AS1 transfected HCC1937 cell group ( Figure 6A, P<0.01) . Tumor volume was measured every 5 days and tumor weight was detected at day 30. The results showed that though tumor volume and weight were increased in all three groups, while tumor volume were increased significantly in DSCAM-AS1 group compared to other groups, indicating overexpression of DSCAM-AS1 promoted tumor growth and knockdown of DSCAM-AS1 largely promoted tumor growth ( Figure 6B-D, P<0.05) . Besides, qRT-PCR revealed that miR-204-5p expression was down-regulated after overexpression of DSCAM-AS1, whereas the expression of miR-204-5p was up-regulated after knockdown of DSCAM-AS1 in HCC1037 transplants ( Figure 6E, P<0.01 ).
Furthermore, overexpression of DSCAM-AS1 improved RRM2 mRNA and protein expressions ( Figure 6F-G, P<0.01) . Therefore, these data lead to the conclusion that DSCAM-AS1 promoted tumor growth by inhibiting miR-204-5p and promoting the expression of RRM2.
Discussion
A number of publications have confirmed that lncRNAs are associated with tumorigenesis in BC (Cui et al., 2017) . In the present study, the effects of lncRNA DSCAM-AS1 on BC have been investigated. Firstly, we found that DSCAM-AS1 was significantly up-regulated, while miR-204-5p
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was down-regulated in BC cells through microarray analysis and qRT-PCR. Secondly, we revealed that DSCAM-AS1 directly targeted on miR-204-5p by dual- MiR-204-5p has been predicted as an anti-oncogenic molecule in multiple types of cancers (Luo et al., 2017) . Several publications have reported that the miR-204-5p expression was down-regulated 1 6
in various tumors and acted as a potent tumor suppressor inhibiting tumor proliferation and metastasis, including hepatocellular carcinoma, oral squamous cell carcinoma and BC (Jiang et al., 2016; Wang et al., 2016; Zeng et al., 2016) . , 2015) . Consistently, we found that RRM2 was up-regulated in BC. Meanwhile, a series of experimental results indicated that the effects of RRM2 on BC cell activities were reversely changed by miR-204-5p. We clearly investigated the molecular mechanism underlying DSCAM-AS1, miR-204-5p and RRM2 and revealed their relationship in BC for the first time.
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However, some shortages of our study should be considered in our following researches. For instance, in vitro experiments of DSCAM-AS1 and RRM2 should be conducted to comprehensively understand the molecular network of DSCAM-AS1, miR-204-5p and RRM2 in BC.
Conclusion
In conclusion, we validated that DSCAM-AS1 was elevated in BC cells, DSCAM-AS1 promoted the proliferation and metastasis of BC cells and suppressed cell apoptosis by inhibiting miR-204-5p
and increasing RRM2 expression. Therefore, this study suggests that inhibition of DSCAM-AS1 may be a promising therapeutic strategy for treatment of BC.
Disclosure 1 9 Flow cytometry showed that apoptosis rate in DSCAM-AS1 group was lower than that in NC group, while that in miR-204-5p group was much higher than that in NC group. ** P<0.01, compared with NC group. with NC+ RRM2 wt group. (B) QRT-PCR revealed that RRM2 expression was up-regulated in tumor tissues. * P<0.05, compared with normal tissues. (C) Western blot showed that RRM2 protein expression in tumor tissues was higher than that in normal tissues. (D) QRT-PCR revealed that RRM2 expression in miR-204-5p group was significantly lower than that in NC group. ** P<0.01, compared with NC group. (E) Western blot showed that RRM2 protein expression decreased in HCC1937 cells when co-transfected with miR-204-5p. Transwell assay showed that compared with NC group, more migrating or more invasive cells were found in RRM2 group while less metastasis cells were observed in miR-204-5p group. (E) Flow cytometry indicated that apoptosis rate in RRM2 group was lower than that in NC group, while apoptosis rate in miR-204-5p group was higher than that in NC group. ** P<0.01, compared with NC group. QRT-PCR revealed that miR-204-5p expression in DSCAM-AS1 group was significantly lower than that in NC group. (F) QRT-PCR showed that RRM2 expression was significantly higher in DSCAM-AS1 group compared with NC group. (G) Western blot revealed that RRM2 protein expression in DSCAM-AS1 group was significantly higher than that in NC group. 
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